December 5, 2023 Zepbound Released to Market A month after getting FDA approval, Zepbound was released to market and available at retail and mail-order pharmacies
Clinical trials demonstrated that users on semaglutide therapy lost an average of 22 pounds over 68 weeks compared to 4 pounds in placebo groups
It does so by acting as an agonist a substance that mimics the naturally occurring hormone by attaching to the same cell receptors in the brain and producing a similar or enhanced response in the body, including improved insulin release, lower appetite and slow digestion
Anker SD et al (2025) Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency, (in eng)
Educating the population about healthy living, providing resources and supports to make healthier choices, and ensuring that pharmacotherapy is used as a part of a comprehensive care plan, rather than a standalone solution, will be significant in ensuring long-term health outcomes
Your body burns fewer calories as you lose weighta biological fact requiring patience rather than medication change